Continuous care. Human connection.
Help your team turn everyday progress into timely, individualised support — and build a stronger care relationship with patients and families.
Who we work with
Clinical effect
Evira strengthens the alliance with families through regular feedback and support. In a Swedish pragmatic trial, the larger reduction in BMI Z-score after one year was maintained at three years.
Average BMI Z-score over three years for the digi-physical treatment group and matched standard-treatment group, adjusted for sex, age and degree of obesity at treatment start. This Swedish study is not an NHS service outcome.
Read the peer-reviewed three-year study →Evira in the NHS
Evira is used alongside different models of specialist CEW care — from regional hubs and local spokes to home-first and hybrid pathways.
Explore public evidence, implementation experience and service outcomes from NHS teams across England.
NHS CEW services featured
Hubs + spokes
NHS England regions
Cases span published Evira evaluations, service outcomes, pathway redesign and real-world implementation.
Find your service
Explore the priorities, care model and practical next steps for your team.
A family-centred approach to obesity care, from community services through to specialist treatment.
Support children and young people with complex needs, alongside your specialist MDT.
Build family engagement and ongoing follow-up into your local childhood obesity pathway.
Connect monitoring and behavioural support across adult obesity treatment.
Tier 2 programmes, medication-supported care, transition services, learning disability services and research collaborations all build on the same continuous-care model.
The Evira approach
A meaningful change in a patient's progress can happen long before their next visit. Evira connects home monitoring with clinical judgement, helping your team respond when support is needed.
A numberless scale and app help patients and families follow progress against an individual treatment goal.
Patient & familyYour care team reviews progress between visits, alongside the patient's circumstances and clinical needs.
Clinical teamUse personal feedback to recognise progress, work through difficulties and agree the next step together.
A shared conversationAlongside appointments, with review frequency and clinical responsibility agreed by your service. Evira supports treatment delivered by your team; it is not a separate care provider.
In the CEW clinic
Specialist teams describe the difference as knowing sooner — and being able to act while it still matters.
Obesity is a chronic condition — yet most services still deliver short, clinic-bound 12-week programmes. They are resource-heavy, hard to sustain and end up driving repeat demand. In England, 66% of adults and 26% of children aged 2–15 are overweight or living with obesity.
Evira takes a different route: continuous digital support running alongside clinical care, so teams can deliver long-term follow-up without scaling staff in proportion. Sustained behavioural change instead of episodic care.
NHS Digital 2024 · Health Survey for England, Jan 2026
Evira bridges the gap between clinic visits with daily remote monitoring, family messaging and proactive intervention — so teams can deliver high-quality care even when distances are great.
A connected scale at home — no numbers shown. Daily measurements flow straight to the clinical dashboard.
Families reach their care team whenever they need to. AI-powered translation supports multilingual populations.
The full treatment history is available to the multidisciplinary team. Search, filter and sort. 2–4 minutes per patient per week.
Individualised height-growth predictions yield real-time, accurate BMI SDS values for children and young people.
Simple visual indicators for varying health literacy plus AI translation in messaging — accessible to diverse populations.
Several household members can use the same device with separate secure accounts — supporting family-wide collaboration.
Around 10% of children in UK CEW services using Evira are now also receiving GLP-1 medication. Evira provides the behavioural monitoring, dosing communication and lifestyle support that make pharmacotherapy more effective.
Learn about Evira & GLP-1 →DTAC, DSPT, Cyber Essentials, DCB0129, CE marked, ICO registered. We provide complete evidence packs to accelerate your procurement.
Digital Technology Assessment Criteria.
Clinical risk management standards.
Data Security & Protection Toolkit.
Medical device, class I.
Certified for Cyber Essentials.
UK GDPR compliant.
We can provide a complete DTAC evidence pack, help you complete DPIA templates, and supply data processing agreements. View full compliance documentation →
Clinically validated in published, peer-reviewed research with Karolinska Institutet
Roughly twice the effect of traditional treatment when using Evira.
Treatment effects maintained at three-year follow-up. KI 2025.
Compared with 11% in traditional care — particularly strong in adolescents.
By shifting care from clinic-based to digital-first delivery, Evira reduces environmental impact across the pathway.
Home-based monitoring and digital follow-up replace many in-person visits — fewer journeys for patients and staff.
The numberless scale is durable, reusable, and refurbishable when returned. Several household members share one device.
Less reliance on printed materials. Digital communication replaces letters and paper forms.
Clinicians can review dashboards and reply to messages remotely, reducing staff travel where appropriate.
A scalable solution for long-term weight management — built to support ICB and Trust priorities in prevention, inequalities, sustainability and cost efficiency.
Book a demonstration